Efficacy of Intraoperative Magnesium Sulphate vs Dexmedetomidine on Emergence Agitation in Pediatric Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

November 1, 2024

Study Completion Date

February 10, 2025

Conditions
Magnesium SulphateDexmedetomidineEmergence AgitationPediatric Patients
Interventions
DRUG

Magnesium sulphate

Patients received an initial intravenous loading dose of 30 mg/kg of 10% magnesium sulfate solution over 10 min. This will be followed by a continuous infusion of (10mg/kg/hr) for the entire duration of surgery.

DRUG

Dexmedetomidine

Patients received dexmedetomidine infusion 0.5 μg/kg over 10 min as a bolus dose, followed by 0.2 μg/kg/h all over the operation.

Trial Locations (1)

11591

Ain shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06977425 - Efficacy of Intraoperative Magnesium Sulphate vs Dexmedetomidine on Emergence Agitation in Pediatric Patients | Biotech Hunter | Biotech Hunter